Fair Value Calculator Fair Value Calculator
EN DE

0261 (0261) Fair Value & Analysis

Industrials · Market cap HK$51.0M

0 0261 0261 · HK
PriceHK$0.1790
Fair ValueHK$0.1087
Upside-39.3%
Quality37/100
Evidence: Low Range HK$0.0717 – HK$0.1360

Fair value as of: Jul 1, 2026

From 1 valuation models · updated today

Share price −6.3% over the past month.

Price vs Fair Value (12 months)

HK$0.3600 HK$0.1750 Fair Value HK$0.1087 Jun 2025 Jun 2026

12‑month range HK$0.1750 – HK$0.3600 · fair‑value band HK$0.0717 – HK$0.1360 · the HK$0.1790 price screens above the HK$0.1087 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0261 (0261) currently trades at HK$0.1790, while our model-based Fair Value estimate is HK$0.1087 — implying the stock looks roughly 39.3% overvalued today. We read business quality at 37/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 0261 generated revenue of HK$127M at a net margin of -88.5%. Revenue grew 244.4% year over year. It earns a return on equity of -22.2%. The balance sheet holds a net cash position of HK$21.4M. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$127M
Revenue growth (YoY) +244%
Net margin -88.5%
Return on equity -22.2%
Free cash flow −HK$7.8M FY2025
Operating margin -77.2%
More key figures
EPS (TTM) HK$-0.1500
Net cash HK$21.4M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0261 reported revenue of HK$127M in FY2025 versus HK$469M in FY2021, a compound −27.9%/yr. Reported net income was −HK$112M in FY2025.

Revenue −27.9%/yr
FY21 HK$469M
FY22 HK$56.0M
FY23 HK$78.4M
FY24 HK$57.0M
FY25 HK$127M
Net income
FY21 −HK$60.0M
FY22 −HK$175M
FY23 −HK$98.4M
FY24 −HK$55.8M
FY25 −HK$112M

Is 0261 fairly valued? → Check now

Similar stocks

6 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock Price Fair Value vs Fair Value
Honeywell International Inc HON C$25.91 C$16.17 -38%
Hitachi, Ltd HTHIY $29.38 $23.57 -20%
CITIC Limited 0267 HK$12.30 HK$37.22 +203%
0019 0019 HK$81.70 HK$13.77 -83%
CK Hutchison Holdings 0001 HK$67.00 HK$105.00 +57%
Itaúsa S.A ITSA3 R$13.05 R$13.52 +4%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0261 (0261) undervalued?
As of Jul 1, 2026, our model estimates a fair value of HK$0.1087 versus a price of HK$0.1790 — about −39% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 0261?
Our model-based fair value for 0261 is HK$0.1087 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.1790.
What is the quality score of 0261?
0261 has a Quality Score of 37/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0261 (0261)?
0261 reported trailing-twelve-month revenue of about HK$127M (latest available figure, as of Jul 1, 2026).
What is the net profit margin of 0261?
The net profit margin of 0261 is about -88.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.